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LETTER TO THE EDITOR
Molecular genetic basis of Wilms' tumour?
Sir - I read the paper 'Molecular genetic analysis of
chromosome lip in familial Wilms' tumour' by Baird et al.
(1994) with interest. The data make it unlikely that the
candidate locus is at lIp or 16q and therefore other loci need
to be examined. The next region to exclude should be
Xq25-27, which has been linked to the overgrowth synd-
rome Simpson-Golabi-Behmel (Hughes-Benzie et al.,
1992a; Xuan et al., 1994). This disorder is associated with
embryonal tumours, including Wilms' tumours (Xuan et al.,
1994), and may be mistaken for Beckwith-Wiedemann synd-
rome (BWS) (Hughes-Benzie et al., 1992b). It is unusual in
that, although the phenotype is more marked in males, as
would be expected in an X-linked recessive condition, a
predisposition to Wilms' tumours in females may exist (Xuan
et al., 1994).
It should also be mentioned that from the published data
in Baird et al.'s paper one could also postulate a mechanism,
albeit an unlikely one, which is based on uniparental disomy
(UPD). This would necessitate both GOS 250 and GOS 416
having uniparental heterodisomy owing to a meiotic error
and a subsequent mitotic recombination resulting in
isodisomy distal to the breakpoint in GOS 250, the latter
being a well-recognised phenomenon in BWS. This chain of
events requires three rare events and a different mechanism in
the mother. In addition, maternal disomy would be expected
to result in the absence of insulin-like growth factor 2 expres-
sion (not the normal monoallelic expression seen in this
report), and would therefore require an unidentified 'event'
to remove the maternal imprint. The relevance of this rather
convoluted discussion is to stress that heterozygosity alone
does not exclude UPD; this can only be achieved by proving
biparental inheritance. This may well have been done by the
authors, but the absence of critical paternal typings prevents
the reader from knowing this.
Yours etc.
TRP Cole
Consultant Clinical Geneticist,
Birmingham Maternity Hospital,
Edgbaston,
Birmingham B15 2TG, UK.
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